Found: 4
Select item for more details and to access through your institution.
A Novel BD2-Selective Inhibitor of BRDs Mitigates ROS Production and OA Pathogenesis.
- Published in:
- Antioxidants, 2024, v. 13, n. 8, p. 943, doi. 10.3390/antiox13080943
- By:
- Publication type:
- Article
BRD2‐specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis‐induced C57BL/6 male mice.
- Published in:
- British Journal of Pharmacology, 2024, v. 181, n. 15, p. 2528, doi. 10.1111/bph.16359
- By:
- Publication type:
- Article
Tissue pharmacokinetics of DHP107, a novel lipid‐based oral formulation of paclitaxel, in mice and patients by positron emission tomography.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 5, p. 1747, doi. 10.1111/cts.13003
- By:
- Publication type:
- Article
Antitumour effects of Liporaxel (oral paclitaxel) for canine melanoma in a mouse xenograft model.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 152, doi. 10.1111/vco.12540
- By:
- Publication type:
- Article